The Discounted Cash Flow (DCF) valuation of OncoCyte Corp (OCX) is (523.48) USD. With the latest stock price at 3.20 USD, the upside of OncoCyte Corp based on DCF is -16458.6%.
Based on the latest price of 3.20 USD and our DCF valuation, OncoCyte Corp (OCX) is a sell. selling OCX stocks now will result in a potential gain of 16458.6%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 9.0% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,821.93) - (305.89) | (523.48) |
| Upside | -57035.4% - -9658.9% | -16458.6% |